Variation in Prostate Specific Antigen (PSA) test ordering in primary care centers: Tendencies 2002-2009

Clinical Laboratory

Volumn 58, Issue 5-6, 2012, Pages 573-577

  Lumbreras, Blanca ^a,b   López Garrigos, Maite ^c   Salinas, María ^c  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

Author keywords

Laboratory; Prostate specific antigen; Variability

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONSENSUS; CONTROLLED STUDY; DIAGNOSTIC TEST; GENERAL PRACTITIONER; GROUPS BY AGE; HEALTH CARE QUALITY; HUMAN; LABORATORY TEST; MALE; PREDICTIVE VALUE; PRIMARY HEALTH CARE; SPAIN;

ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD CHEMICAL ANALYSIS; DIAGNOSTIC TESTS, ROUTINE; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC DISEASES;

EID: 84863699496     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Kell JS. Prostate-specific antigen tests and prostate cancer screening: an update for primary care physicians. Can J Urol 2010;17:18-25.
2. Prostate-Specific Antigen (PSA) Best Practice Policy. American Urological Association (AUA). Oncology 2000;14:267-86.
3. Programa de Actividades Preventivas y Promoción de la Salud (PAPPS). Sociedad Española de Medicina de Familia y Comunitaria (semFYC). Barcelona, 1999.
4. rd, et al. PLCO Project Team. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 2009;360:1310-9.
5. Schröder FH, Hugosson J, Roobol MJ Tammela TL et al; ERSPC Investigators. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009;360:1320-8.
6. Stark JR, Mucci L, Rothman KJ, Adami HO. Screening for prostate cancer remains controversial. BMJ 2009;339:b3601.
7. Sirovich BE, Schwartz LM, Woloshin S. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? JAMA 2003;289:1414-20. (Pubitemid 37430309)
8. Tudiver F, Brown JB, Medved W, Herbert C, Ritvo P, Guibert R. Making decisions about cancer screening when the guidelines are unclear or conflicting. J Fam Pract 2001;50:682-7. (Pubitemid 32757846)
9. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin 2006;56:11-25. (Pubitemid 43228384)
10. Verstappen WH, ter Riet G, Dubois WI, Winkens R, Grol RP, van der Weijden T. Variation in test ordering behaviour of GPs: professional or context-related factors? Fam Pract 2004;21:387-95. (Pubitemid 39162007)
11. Leurquin P, Van Casteren V, De Maeseneer J. Use of blood tests in general practice: a collaborative study in eight European countries. Eurosentinel Study Group. Br J Gen Pract 1995;45:21-5.
12. Haggerty J, Tudiver F, Brown JB, Herbert C, Ciampi A, Guibert R. Patients' anxiety and expectations: how they influence family physicians' decisions to order cancer screening tests. Can Fam Physician 2005;51:1658-9. (Pubitemid 44661548)
13. Linder SK, Hawley ST, Cooper CP, Scholl LE, Jibaja-Weiss M, Volk RJ. Primary care physicians' reported use of pre-screening discussions for prostate cancer screening: a cross-sectional survey. BMC Fam Pract 2009;10:19.
14. Chan EC, Barry MJ, Vernon SW, Ahn C. Brief report: physicians and their personal prostate cancer-screening practices with prostate-specific antigen. A national survey. J Gen Intern Med 2006; 21:257-9.